∗Center for Neurointestinal Health, Massachusetts General Hospital
†Harvard Medical School
‡Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, MA
§Center for Neurogastroenterology and Motility Disorders, Connecticut Children's Medical Center, Hartford, CT
||Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA.
Address correspondence and reprint requests to Helen Burton Murray, PhD, Division of Gastroenterology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 (e-mail: [email protected]).
Received 17 March, 2021
Accepted 16 September, 2021
This article has been developed as a Journal CME and MOC Part II Activity by NASPGHAN. Visit https://learnonline.naspghan.org/ to view instructions, documentation, and the complete necessary steps to receive CME and MOC credits for reading this article.
Drs Helen Burton Murray and Fatima U. Rao contributed equally to this work.
Grant support: This manuscript was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, K23 DK120945 (KS) and K23 DK131334 (HBM).
Conflicts of Interest: B.K. has received research support from AstraZeneca, Takeda, Gelesis, Medtronic, Genzyme and has served as a consultant to Shire, Takeda, and Ironwood. K.S. has received research support from Takeda, Ironwood, and Urovant, has been a speaker for Shire, and a consultant for Arena, Boston Pharmaceuticals, and Gelesis. J.J.T. receives royalties from Cambridge University Press for the sale of her books on avoidant/restrictive food intake disorder. All other authors have no personal or financial conflicts to declare.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal's Web site (www.jpgn.org).
